Röcken, Jonathan
Schumann, Desiree M.
Herrmann, Matthias J.
Veitz, Simon
Franchetti, Léo
Grize, Leticia
Strobel, Werner
Jahn, Kathleen
Tamm, Michael
Stolz, Daiana
Funding for this research was provided by:
Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel
Universitätsklinikum Freiburg
Article History
Received: 11 October 2022
Accepted: 11 June 2023
First Online: 22 July 2023
Declarations
:
: The Ethikkommission Beider Basel, approved the study (EKNZ 2018-01789) and the subjects provided written informed consent. This study was conducted in accordance with the amended Declaration of Helsinki.
: All subjects provided written informed consent.
: DS received grants or contracts from Astra-Zeneca AG, Curetis AG and Boston Scientific. DS and MT received consulting fees from Astra Zeneca AG, Sanofi, MSD and Novartis. DS and MT received payment or honoraria for lectures, presentations, speakers bureaus, or educational events from Astra-Zeneca AG, Novartis AG, GSK AG, Roche AG, Schwabe Pharma AG, Vifor AG, Chiesi AG, MSD and Sanofi. JR received payment for a presentation from Astra Zeneca AG. DS participated on a data safety monitoring board or advisory board of CSL Behring. No other author has any conflict of interest/competing interest.